This company is no longer activeThe company may no longer be operating, as it may be out of business. Find out why through their latest events.See Latest EventsDanimer Scientific（6CU）株式概要パフォーマンス・ポリマー企業であるダニマー・サイエンティフィック社は、米国、ドイツ、ポーランド、ベルギー、オーストリア、そして国際的に、従来の石油由来プラスチックに代わるバイオプラスチックを提供している。 詳細6CU ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長2/6過去の実績0/6財務の健全性2/6配当金0/6報酬収益は年間42.03%増加すると予測されています リスク分析株式の流動性は非常に低い キャッシュランウェイが1年未満である 現在は利益が出ておらず、今後3年間で利益が出る見込みはない 過去1年間で株主の希薄化が進んだ +1 さらなるリスクすべてのリスクチェックを見る6CU Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€1.548.2% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-190m260m2016201920222025202620282031Revenue US$260.0mEarnings US$24.4mAdvancedSet Fair ValueView all narrativesDanimer Scientific, Inc. 競合他社BRAIN BiotechSymbol: XTRA:BNNMarket cap: €70.8mNabaltecSymbol: XTRA:NTGMarket cap: €93.7mH&R GmbH KGaASymbol: XTRA:2HRAMarket cap: €172.0mUzin UtzSymbol: XTRA:UZUMarket cap: €313.8m価格と性能株価の高値、安値、推移の概要Danimer Scientific過去の株価現在の株価US$1.5452週高値US$1.5452週安値US$0.91ベータ1.621ヶ月の変化0%3ヶ月変化0%1年変化n/a3年間の変化n/a5年間の変化n/aIPOからの変化-83.77%最新ニュースお知らせ • Nov 16Danimer Scientific, Inc. announced delayed 10-Q filingOn 11/15/2024, Danimer Scientific, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 05Danimer Scientific Announces Intention to Complete a Reverse Stock Split to Regain Compliance with the Price Criteria of Section 802.01C of the NYSE Listed Company ManualDanimer Scientific, Inc. announced that, following approval by the Company's stockholders and its Board of Directors, the Company will effect a reverse stock split ('Reverse Stock Split') of Danimer's Class A common stock, par value $0.0001 per share ('Common Stock'), at a ratio of 1-for-40 (the 'Reverse Stock Split Ratio'), which ratio was determined by the Board of Directors from within a range of ratios authorized by the stockholders. The Reverse Stock Split is expected to become effective on November 12, 2024, after close of trading on the New York Stock Exchange ('NYSE'). The Common Stock is expected to begin trading on a split-adjusted basis when the markets open on November 13, 2024, under the existing trading symbol 'DNMR' and new CUSIP number (236272 407). The Company believes the Reverse Stock Split will increase the price per share of the Common Stock and thus enable it to regain compliance with the price criteria of Section 802.01C of the NYSE Listed Company Manual (the 'Minimum Share Price Rule').お知らせ • Oct 28Danimer Scientific Announces Second Circuit Court Affirms Dismissal of Class Action LawsuitDanimer Scientific, Inc. announced that, on September 27, 2024, the United States Court of Appeals for the Second Circuit affirmed the 2023 Order of the United States District Court for the Eastern District of New York dismissing a previously disclosed putative class action complaint captioned In re Danimer Scientific, Inc. Securities Litigation. Subsequently, the plaintiffs in the three shareholder derivative cases that had been pending in state and federal courts in Delaware, which cases had been stayed pending the outcome of the Second Circuit case, dismissed their complaints.お知らせ • Oct 15+ 2 more updatesDanimer Scientific, Inc. to Report Q3, 2024 Results on Nov 14, 2024Danimer Scientific, Inc. announced that they will report Q3, 2024 results After-Market on Nov 14, 2024お知らせ • Aug 09Danimer Scientific, Inc. Provides Financial Guidance for the Second Quarter of Fiscal 2025Danimer Scientific, Inc. provides financial guidance for the second quarter of fiscal 2025. For the period, the company expects annualized PHA revenues to more than triple, based solely on demand from existing customer relationships and their indicated volumes, including the aforementioned 20-million-pound cutlery award.お知らせ • Aug 02Danimer Scientific, Inc. to Report Q2, 2024 Results on Aug 08, 2024Danimer Scientific, Inc. announced that they will report Q2, 2024 results After-Market on Aug 08, 2024最新情報をもっと見るRecent updatesお知らせ • Nov 16Danimer Scientific, Inc. announced delayed 10-Q filingOn 11/15/2024, Danimer Scientific, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 05Danimer Scientific Announces Intention to Complete a Reverse Stock Split to Regain Compliance with the Price Criteria of Section 802.01C of the NYSE Listed Company ManualDanimer Scientific, Inc. announced that, following approval by the Company's stockholders and its Board of Directors, the Company will effect a reverse stock split ('Reverse Stock Split') of Danimer's Class A common stock, par value $0.0001 per share ('Common Stock'), at a ratio of 1-for-40 (the 'Reverse Stock Split Ratio'), which ratio was determined by the Board of Directors from within a range of ratios authorized by the stockholders. The Reverse Stock Split is expected to become effective on November 12, 2024, after close of trading on the New York Stock Exchange ('NYSE'). The Common Stock is expected to begin trading on a split-adjusted basis when the markets open on November 13, 2024, under the existing trading symbol 'DNMR' and new CUSIP number (236272 407). The Company believes the Reverse Stock Split will increase the price per share of the Common Stock and thus enable it to regain compliance with the price criteria of Section 802.01C of the NYSE Listed Company Manual (the 'Minimum Share Price Rule').お知らせ • Oct 28Danimer Scientific Announces Second Circuit Court Affirms Dismissal of Class Action LawsuitDanimer Scientific, Inc. announced that, on September 27, 2024, the United States Court of Appeals for the Second Circuit affirmed the 2023 Order of the United States District Court for the Eastern District of New York dismissing a previously disclosed putative class action complaint captioned In re Danimer Scientific, Inc. Securities Litigation. Subsequently, the plaintiffs in the three shareholder derivative cases that had been pending in state and federal courts in Delaware, which cases had been stayed pending the outcome of the Second Circuit case, dismissed their complaints.お知らせ • Oct 15+ 2 more updatesDanimer Scientific, Inc. to Report Q3, 2024 Results on Nov 14, 2024Danimer Scientific, Inc. announced that they will report Q3, 2024 results After-Market on Nov 14, 2024お知らせ • Aug 09Danimer Scientific, Inc. Provides Financial Guidance for the Second Quarter of Fiscal 2025Danimer Scientific, Inc. provides financial guidance for the second quarter of fiscal 2025. For the period, the company expects annualized PHA revenues to more than triple, based solely on demand from existing customer relationships and their indicated volumes, including the aforementioned 20-million-pound cutlery award.お知らせ • Aug 02Danimer Scientific, Inc. to Report Q2, 2024 Results on Aug 08, 2024Danimer Scientific, Inc. announced that they will report Q2, 2024 results After-Market on Aug 08, 2024お知らせ • Jun 13+ 14 more updatesDanimer Scientific, Inc.(UNQ:) dropped from Russell 2000 Value IndexDanimer Scientific, Inc.(UNQ:) dropped from Russell 2000 Value Indexお知らせ • May 25Danimer Scientific, Inc. Receives Non-Compliance Notice from NYSE RegulationOn May 21, 2024, Danimer Scientific, Inc. (the Company") was notified by NYSE Regulation (NYSER") that the Company is not in compliance with the New York Stock Exchange's (NYSE") continued listing criteria under Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company's common stock was less than $1.00 over a consecutive 30 trading-day period as of May 20, 2024. The Company has notified the NYSE of its intent to cure the deficiency and return to compliance with the NYSE continued listing requirements. The Company will return to compliance if, during the six-month period following receipt of the NYSE notice, on the last trading-day of any calendar month, the Company's common stock has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. Under NYSE rules, the Company's common stock will continue to be traded on the NYSE during this period, subject to the Company's compliance with other applicable continued listing requirements. The NYSER notification does not affect the Company's business operations, Securities and Exchange Commission reporting requirements or debt obligations.お知らせ • May 07Danimer Scientific Reveals New Branding and New Applications Based on PHA During NPE 2024Danimer Scientific, Inc. is unveiling new commercial applications and branding during NPE 2024, North America’s large plastics tradeshow, taking place this week in Orlando, FL. A more perfect polymer™ takes center stage at NPE 2024. Danimer’s signature PHA, Nodax®, represents a more perfect polymer revolution. PHAs (polyhydroxyalkanoates) are naturally made polymer chains, and at Danimer it harness microbes as tiny reactors to make its biopolymers, using canola oil as the renewable feedstock. The resulting PHA can be used to replace conventional plastics in uses from straws to lids, from coffee pods to flexible packaging, and from paper coatings to adhesives. With full PHA production capability in place, Danimer is poised for significant growth with commercial partners for several applications, including cutlery, flexible food packaging and paper packaging barrier coatings. Microbes, not Microplastics™ enables a new future for packaging items. Danimer is committed to offering solutions to address plastic pollution and the proliferation of microplastics. It is all about the microbes, both during origination and biodegradation. Microbes produce PHAs, and microbes biochemically recycle its PHAs, whether in industrial compost, home compost, soils, fresh water or the marine environment. Because a large class of microbes present in natural systems readily identify PHAs as a food source, there is no threat of residual microplastics. PHA grades are third party certified to fully biodegrade under various conditions, with the added benefit of no ecotoxicity concerns, PFAS or regulated metals. That makes Nodax a more perfect polymer™ for its planet.お知らせ • May 05Danimer Scientific, Inc., Annual General Meeting, Jul 09, 2024Danimer Scientific, Inc., Annual General Meeting, Jul 09, 2024.お知らせ • May 03Danimer Scientific, Inc. to Report Q1, 2024 Results on May 07, 2024Danimer Scientific, Inc. announced that they will report Q1, 2024 results After-Market on May 07, 2024Reported Earnings • Mar 30Full year 2023 earnings released: US$1.52 loss per share (vs US$1.78 loss in FY 2022)Full year 2023 results: US$1.52 loss per share (improved from US$1.78 loss in FY 2022). Revenue: US$46.7m (down 12% from FY 2022). Net loss: US$155.5m (loss narrowed 14% from FY 2022). Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany.お知らせ • Mar 26Danimer Scientific, Inc. has completed a Follow-on Equity Offering in the amount of $14.999625 million.Danimer Scientific, Inc. has completed a Follow-on Equity Offering in the amount of $14.999625 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 11,250,000 Price\Range: $1 Discount Per Security: $0.07 Security Name: Warrants Security Type: Equity Warrant Securities Offered: 15,000,000 Security Name: Pre-Funded Warrants Security Type: Equity Warrant Securities Offered: 3,750,000 Price\Range: $0.9999 Discount Per Security: $0.06993 Transaction Features: Registered Direct OfferingNew Risk • Mar 24New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 12% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$92m net loss in 3 years). Shareholders have been diluted in the past year (12% increase in shares outstanding).お知らせ • Mar 21Danimer Scientific, Inc. has filed a Follow-on Equity Offering in the amount of $34.95 million.Danimer Scientific, Inc. has filed a Follow-on Equity Offering in the amount of $34.95 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 15,000,000 Price\Range: $1 Security Name: Warrants Security Type: Equity Warrant Securities Offered: 15,000,000 Price\Range: $1.33 Transaction Features: Registered Direct Offeringお知らせ • Jan 31Danimer Scientific Receives Continued Listing Standard Notice from NYSEDanimer Scientific, Inc. announced that it received a notice from the New York Stock Exchange ('NYSE') on January 23, 2024, that the Company is not currently in compliance with the NYSE's continued listing standard requiring listed-company stock to maintain an average closing price of not less than $1.00 per share over a period of thirty (30) consecutive trading days. The Notice does not result in the immediate delisting of the Company's Common Stock from the NYSE. On January 26, 2024, the Company notified the NYSE that it intends to cure the stock price deficiency and return to compliance with the NYSE's minimum share price standard within the six-month period following receipt of the Notice. The Company's Common Stock will continue to be listed and trade on the NYSE during this period, subject to its compliance with other NYSE continued listing standards. The receipt of the Notice does not affect the Company's business, operations or reporting requirements with the Securities and Exchange Commission. The Company intends to consider all available options to cure its non-compliance with the NYSE minimum share price standard. The Company can regain compliance with the minimum share price requirement at any time during the six-month cure period if, on the last trading day of any calendar month during the cure period or on the last day of the cure period, the Company has (i) a closing share price of at least $1.00, and (ii) an average closing share price of at least $1.00 over the 30 trading-day periods ending on the last trading day of that month.お知らせ • Jan 19Danimer Scientific, Inc. Announces New DirectorsDanimer Scientific, Inc. announced that Dr. David Moody and Mr. Richard Altice have been appointed as members of Danimer’s Board of Directors. Dr. Moody’s appointment is effective immediately, and Mr. Altice’s appointment is effective as of April 15, 2024. Dr. David J. Moody currently is a member of the Board of Directors of Jadex Inc., a US-based manufacturing and material science company utilizing innovation and technology to develop sustainable products that serve the medical, industrial and consumer markets. Dr. Moody previously served as Chief Executive Officer of Jadex from March 2021 through July 2023, and before that served in various roles of increasing responsibility at Milliken & Company culminating in the role of Executive Vice President and Division President, Chemicals. Dr. Moody has over thirty years’ experience managing chemical and polymer related businesses in various leadership roles and holds a Bachelor of Science in Chemistry from Wofford College and a Ph.D. in Chemistry from the Georgia Institute of Technology. Richard N. Altice most recently retired from NatureWorks, a developer and manufacturer of biopolymers (polylactic acid), where he served as President and CEO for five years. Prior to NatureWorks, Mr. Altice was the Senior Vice President and President of PolyOne’s Designed Structures and Solutions, a polymer and plastics converting and food packaging business, formerly known as Spartech. Additionally, Mr. Altice was Vice President of Hexion’s Global Specialty Epoxy resin business and was formerly the President of Solutia’s Technical Specialties division, responsible for the global rubber chemicals and specialty fluids businesses. Mr. Altice has over thirty years of sales, marketing, operational and management experience in the specialty chemicals and biopolymer industries and holds a Bachelor of Science in Chemical Engineering from the Missouri University of Science and Technology. With these changes, Danimer’s Board will be comprised of eleven directors.お知らせ • Nov 08Danimer Scientific, Inc. to Report Q3, 2023 Results on Nov 14, 2023Danimer Scientific, Inc. announced that they will report Q3, 2023 results After-Market on Nov 14, 2023お知らせ • Oct 20Danimer Scientific, BIOLO and Bolthouse Farms Announce Commercialization of Home Compostable Packaging for Fresh Produce with Meijer StoresDanimer Scientific, Inc. announced the commercialization of home compostable retail packaging for vegetables and fruit, which Danimer developed in partnership with biodegradable packaging and food service product manufacturer BIOLO and carrot producer Bolthouse Farms. Danimer’s signature PHA, Nodax®, was used to create the bags for one-pound Earthbound Farm Organic Mini Peeled Carrots, now available in Meijer’s regional network of 240 grocery stores and supercenters in six states across the Midwest. Danimer’s Nodax® is a biobased polyester made with oils derived from the seeds of plants such as canola. Unlike traditional plastic, which can take centuries to degrade, Danimer’s PHA-based products can degrade in a matter of months under certain conditions. The Earthbound Farm Organic Mini Peeled Carrots bags are certified as home compostable by TUV, a globally recognized leader in independent product testing, inspection and certification. This certification means that the bags have passed rigorous testing that requires them to disintegrate at least 90% within 26 weeks and biodegrade within 52 weeks under home compost conditions.お知らせ • Aug 01Danimer Scientific, Inc. to Report Q2, 2023 Results on Aug 08, 2023Danimer Scientific, Inc. announced that they will report Q2, 2023 results After-Market on Aug 08, 2023お知らせ • May 04Danimer Scientific, Inc. to Report Q1, 2023 Results on May 10, 2023Danimer Scientific, Inc. announced that they will report Q1, 2023 results at 4:00 PM, US Eastern Standard Time on May 10, 2023お知らせ • Nov 09Danimer Scientific, Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2022Danimer Scientific, Inc. reported impairment charges for the third quarter ended September 30, 2022. For the quarter, the company reported impairment of goodwill of $62,663,000.お知らせ • Oct 26Danimer Scientific, Inc. to Report Q3, 2022 Results on Nov 08, 2022Danimer Scientific, Inc. announced that they will report Q3, 2022 results at 4:00 PM, US Eastern Standard Time on Nov 08, 2022お知らせ • Sep 21Danimer Scientific Appoints Stephen Martin as Chief Legal Officer and Corporate SecretaryDanimer Scientific, Inc. announced it has appointed Stephen Martin as Chief Legal Officer and Corporate Secretary. In this role, Martin will manage a wide range of legal matters across the company as Danimer continues to expand its manufacturing capacity to meet demand in the fast-growing bioplastics market.Martin joins Danimer from Kaman Distribution Group, a leading national distributor of highly engineered products and services, where he had served as General Counsel and Corporate Secretary from 2020 until that company’s successful sale earlier this year. Before that, he was General Counsel and Corporate Secretary for Accuride Corporation, a vehicle components manufacturer, starting in 2008. Martin served as an officer in the Air Force from 1992 to 1998, managing the procurement of avionics systems for the Atlas Launch Vehicle system and serving on a satellite command and control squadron responsible for operating a constellation of satellites. He is a distinguished graduate of Squadron Officer School. Martin received his Juris Doctor from Duke University School of Law in 2001, graduating cum laude. He received his master’s from the University of Southern California and his bachelor’s degree from the University of Miami, both in electrical engineering.Recent Insider Transactions • Aug 24Director recently sold €869k worth of stockOn the 19th of August, Stuart Pratt sold around 175k shares on-market at roughly €4.96 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.お知らせ • Aug 17Danimer Scientific, Inc. Elects Board MembersDanimer Scientific, Inc. held its Annual Meeting of Stockholders on August 11, 2022, elected Cynthia Cohen and Allison M. Leopold Tilley to its Board of Directors.株主還元6CUDE ChemicalsDE 市場7D0%-1.8%0.6%1Yn/a4.0%0.2%株主還元を見る業界別リターン: 6CUがGerman Chemicals業界に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。リターン対市場: 6CU German市場に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。価格変動Is 6CU's price volatile compared to industry and market?6CU volatility6CU Average Weekly Movementn/aChemicals Industry Average Movement6.0%Market Average Movement6.1%10% most volatile stocks in DE Market13.2%10% least volatile stocks in DE Market2.7%安定した株価: 6CU 、 German市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 過去 1 年間の6CUのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト2004257Stephen Croskreywww.danimerscientific.comパフォーマンス・ポリマー企業であるダニマー・サイエンティフィック社は、米国、ドイツ、ポーランド、ベルギー、オーストリア、および国際的に、従来の石油由来プラスチックに代わるバイオプラスチックを提供している。同社は、フィルム、ストロー、カトラリー、食品容器などに使用される生分解性プラスチック原料代替品「Nodax」ブランド名のポリヒドロキシアルカノエート、使い捨て紙コップのコーティング用ポリ乳酸系樹脂、その他のバイオポリマーを生産している。同社の製品は、添加剤、水性コーティング剤、繊維、フィラメント、フィルム、熱成形、射出成形品など様々な用途に使用されている。また、消費者向けパッケージング・ブランドのオーナー、コンバーター、プラスチック業界のメーカーにも製品を販売している。ダニマー・サイエンティフィック社は2004年に設立され、ジョージア州ベインブリッジに本社を置いている。もっと見るDanimer Scientific, Inc. 基礎のまとめDanimer Scientific の収益と売上を時価総額と比較するとどうか。6CU 基礎統計学時価総額€73.96m収益（TTM）-€134.25m売上高(TTM)€41.33m1.8xP/Sレシオ-0.6xPER（株価収益率6CU は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計6CU 損益計算書（TTM）収益US$44.98m売上原価US$69.16m売上総利益-US$24.17mその他の費用US$121.92m収益-US$146.10m直近の収益報告Mar 31, 2024次回決算日該当なし一株当たり利益（EPS）-1.25グロス・マージン-53.74%純利益率-324.79%有利子負債／自己資本比率150.3%6CU の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/06/05 17:34終値2024/03/08 00:00収益2024/03/31年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Danimer Scientific, Inc. 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Laurence AlexanderJefferies LLC
お知らせ • Nov 16Danimer Scientific, Inc. announced delayed 10-Q filingOn 11/15/2024, Danimer Scientific, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 05Danimer Scientific Announces Intention to Complete a Reverse Stock Split to Regain Compliance with the Price Criteria of Section 802.01C of the NYSE Listed Company ManualDanimer Scientific, Inc. announced that, following approval by the Company's stockholders and its Board of Directors, the Company will effect a reverse stock split ('Reverse Stock Split') of Danimer's Class A common stock, par value $0.0001 per share ('Common Stock'), at a ratio of 1-for-40 (the 'Reverse Stock Split Ratio'), which ratio was determined by the Board of Directors from within a range of ratios authorized by the stockholders. The Reverse Stock Split is expected to become effective on November 12, 2024, after close of trading on the New York Stock Exchange ('NYSE'). The Common Stock is expected to begin trading on a split-adjusted basis when the markets open on November 13, 2024, under the existing trading symbol 'DNMR' and new CUSIP number (236272 407). The Company believes the Reverse Stock Split will increase the price per share of the Common Stock and thus enable it to regain compliance with the price criteria of Section 802.01C of the NYSE Listed Company Manual (the 'Minimum Share Price Rule').
お知らせ • Oct 28Danimer Scientific Announces Second Circuit Court Affirms Dismissal of Class Action LawsuitDanimer Scientific, Inc. announced that, on September 27, 2024, the United States Court of Appeals for the Second Circuit affirmed the 2023 Order of the United States District Court for the Eastern District of New York dismissing a previously disclosed putative class action complaint captioned In re Danimer Scientific, Inc. Securities Litigation. Subsequently, the plaintiffs in the three shareholder derivative cases that had been pending in state and federal courts in Delaware, which cases had been stayed pending the outcome of the Second Circuit case, dismissed their complaints.
お知らせ • Oct 15+ 2 more updatesDanimer Scientific, Inc. to Report Q3, 2024 Results on Nov 14, 2024Danimer Scientific, Inc. announced that they will report Q3, 2024 results After-Market on Nov 14, 2024
お知らせ • Aug 09Danimer Scientific, Inc. Provides Financial Guidance for the Second Quarter of Fiscal 2025Danimer Scientific, Inc. provides financial guidance for the second quarter of fiscal 2025. For the period, the company expects annualized PHA revenues to more than triple, based solely on demand from existing customer relationships and their indicated volumes, including the aforementioned 20-million-pound cutlery award.
お知らせ • Aug 02Danimer Scientific, Inc. to Report Q2, 2024 Results on Aug 08, 2024Danimer Scientific, Inc. announced that they will report Q2, 2024 results After-Market on Aug 08, 2024
お知らせ • Nov 16Danimer Scientific, Inc. announced delayed 10-Q filingOn 11/15/2024, Danimer Scientific, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 05Danimer Scientific Announces Intention to Complete a Reverse Stock Split to Regain Compliance with the Price Criteria of Section 802.01C of the NYSE Listed Company ManualDanimer Scientific, Inc. announced that, following approval by the Company's stockholders and its Board of Directors, the Company will effect a reverse stock split ('Reverse Stock Split') of Danimer's Class A common stock, par value $0.0001 per share ('Common Stock'), at a ratio of 1-for-40 (the 'Reverse Stock Split Ratio'), which ratio was determined by the Board of Directors from within a range of ratios authorized by the stockholders. The Reverse Stock Split is expected to become effective on November 12, 2024, after close of trading on the New York Stock Exchange ('NYSE'). The Common Stock is expected to begin trading on a split-adjusted basis when the markets open on November 13, 2024, under the existing trading symbol 'DNMR' and new CUSIP number (236272 407). The Company believes the Reverse Stock Split will increase the price per share of the Common Stock and thus enable it to regain compliance with the price criteria of Section 802.01C of the NYSE Listed Company Manual (the 'Minimum Share Price Rule').
お知らせ • Oct 28Danimer Scientific Announces Second Circuit Court Affirms Dismissal of Class Action LawsuitDanimer Scientific, Inc. announced that, on September 27, 2024, the United States Court of Appeals for the Second Circuit affirmed the 2023 Order of the United States District Court for the Eastern District of New York dismissing a previously disclosed putative class action complaint captioned In re Danimer Scientific, Inc. Securities Litigation. Subsequently, the plaintiffs in the three shareholder derivative cases that had been pending in state and federal courts in Delaware, which cases had been stayed pending the outcome of the Second Circuit case, dismissed their complaints.
お知らせ • Oct 15+ 2 more updatesDanimer Scientific, Inc. to Report Q3, 2024 Results on Nov 14, 2024Danimer Scientific, Inc. announced that they will report Q3, 2024 results After-Market on Nov 14, 2024
お知らせ • Aug 09Danimer Scientific, Inc. Provides Financial Guidance for the Second Quarter of Fiscal 2025Danimer Scientific, Inc. provides financial guidance for the second quarter of fiscal 2025. For the period, the company expects annualized PHA revenues to more than triple, based solely on demand from existing customer relationships and their indicated volumes, including the aforementioned 20-million-pound cutlery award.
お知らせ • Aug 02Danimer Scientific, Inc. to Report Q2, 2024 Results on Aug 08, 2024Danimer Scientific, Inc. announced that they will report Q2, 2024 results After-Market on Aug 08, 2024
お知らせ • Jun 13+ 14 more updatesDanimer Scientific, Inc.(UNQ:) dropped from Russell 2000 Value IndexDanimer Scientific, Inc.(UNQ:) dropped from Russell 2000 Value Index
お知らせ • May 25Danimer Scientific, Inc. Receives Non-Compliance Notice from NYSE RegulationOn May 21, 2024, Danimer Scientific, Inc. (the Company") was notified by NYSE Regulation (NYSER") that the Company is not in compliance with the New York Stock Exchange's (NYSE") continued listing criteria under Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company's common stock was less than $1.00 over a consecutive 30 trading-day period as of May 20, 2024. The Company has notified the NYSE of its intent to cure the deficiency and return to compliance with the NYSE continued listing requirements. The Company will return to compliance if, during the six-month period following receipt of the NYSE notice, on the last trading-day of any calendar month, the Company's common stock has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. Under NYSE rules, the Company's common stock will continue to be traded on the NYSE during this period, subject to the Company's compliance with other applicable continued listing requirements. The NYSER notification does not affect the Company's business operations, Securities and Exchange Commission reporting requirements or debt obligations.
お知らせ • May 07Danimer Scientific Reveals New Branding and New Applications Based on PHA During NPE 2024Danimer Scientific, Inc. is unveiling new commercial applications and branding during NPE 2024, North America’s large plastics tradeshow, taking place this week in Orlando, FL. A more perfect polymer™ takes center stage at NPE 2024. Danimer’s signature PHA, Nodax®, represents a more perfect polymer revolution. PHAs (polyhydroxyalkanoates) are naturally made polymer chains, and at Danimer it harness microbes as tiny reactors to make its biopolymers, using canola oil as the renewable feedstock. The resulting PHA can be used to replace conventional plastics in uses from straws to lids, from coffee pods to flexible packaging, and from paper coatings to adhesives. With full PHA production capability in place, Danimer is poised for significant growth with commercial partners for several applications, including cutlery, flexible food packaging and paper packaging barrier coatings. Microbes, not Microplastics™ enables a new future for packaging items. Danimer is committed to offering solutions to address plastic pollution and the proliferation of microplastics. It is all about the microbes, both during origination and biodegradation. Microbes produce PHAs, and microbes biochemically recycle its PHAs, whether in industrial compost, home compost, soils, fresh water or the marine environment. Because a large class of microbes present in natural systems readily identify PHAs as a food source, there is no threat of residual microplastics. PHA grades are third party certified to fully biodegrade under various conditions, with the added benefit of no ecotoxicity concerns, PFAS or regulated metals. That makes Nodax a more perfect polymer™ for its planet.
お知らせ • May 05Danimer Scientific, Inc., Annual General Meeting, Jul 09, 2024Danimer Scientific, Inc., Annual General Meeting, Jul 09, 2024.
お知らせ • May 03Danimer Scientific, Inc. to Report Q1, 2024 Results on May 07, 2024Danimer Scientific, Inc. announced that they will report Q1, 2024 results After-Market on May 07, 2024
Reported Earnings • Mar 30Full year 2023 earnings released: US$1.52 loss per share (vs US$1.78 loss in FY 2022)Full year 2023 results: US$1.52 loss per share (improved from US$1.78 loss in FY 2022). Revenue: US$46.7m (down 12% from FY 2022). Net loss: US$155.5m (loss narrowed 14% from FY 2022). Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany.
お知らせ • Mar 26Danimer Scientific, Inc. has completed a Follow-on Equity Offering in the amount of $14.999625 million.Danimer Scientific, Inc. has completed a Follow-on Equity Offering in the amount of $14.999625 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 11,250,000 Price\Range: $1 Discount Per Security: $0.07 Security Name: Warrants Security Type: Equity Warrant Securities Offered: 15,000,000 Security Name: Pre-Funded Warrants Security Type: Equity Warrant Securities Offered: 3,750,000 Price\Range: $0.9999 Discount Per Security: $0.06993 Transaction Features: Registered Direct Offering
New Risk • Mar 24New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 12% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$92m net loss in 3 years). Shareholders have been diluted in the past year (12% increase in shares outstanding).
お知らせ • Mar 21Danimer Scientific, Inc. has filed a Follow-on Equity Offering in the amount of $34.95 million.Danimer Scientific, Inc. has filed a Follow-on Equity Offering in the amount of $34.95 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 15,000,000 Price\Range: $1 Security Name: Warrants Security Type: Equity Warrant Securities Offered: 15,000,000 Price\Range: $1.33 Transaction Features: Registered Direct Offering
お知らせ • Jan 31Danimer Scientific Receives Continued Listing Standard Notice from NYSEDanimer Scientific, Inc. announced that it received a notice from the New York Stock Exchange ('NYSE') on January 23, 2024, that the Company is not currently in compliance with the NYSE's continued listing standard requiring listed-company stock to maintain an average closing price of not less than $1.00 per share over a period of thirty (30) consecutive trading days. The Notice does not result in the immediate delisting of the Company's Common Stock from the NYSE. On January 26, 2024, the Company notified the NYSE that it intends to cure the stock price deficiency and return to compliance with the NYSE's minimum share price standard within the six-month period following receipt of the Notice. The Company's Common Stock will continue to be listed and trade on the NYSE during this period, subject to its compliance with other NYSE continued listing standards. The receipt of the Notice does not affect the Company's business, operations or reporting requirements with the Securities and Exchange Commission. The Company intends to consider all available options to cure its non-compliance with the NYSE minimum share price standard. The Company can regain compliance with the minimum share price requirement at any time during the six-month cure period if, on the last trading day of any calendar month during the cure period or on the last day of the cure period, the Company has (i) a closing share price of at least $1.00, and (ii) an average closing share price of at least $1.00 over the 30 trading-day periods ending on the last trading day of that month.
お知らせ • Jan 19Danimer Scientific, Inc. Announces New DirectorsDanimer Scientific, Inc. announced that Dr. David Moody and Mr. Richard Altice have been appointed as members of Danimer’s Board of Directors. Dr. Moody’s appointment is effective immediately, and Mr. Altice’s appointment is effective as of April 15, 2024. Dr. David J. Moody currently is a member of the Board of Directors of Jadex Inc., a US-based manufacturing and material science company utilizing innovation and technology to develop sustainable products that serve the medical, industrial and consumer markets. Dr. Moody previously served as Chief Executive Officer of Jadex from March 2021 through July 2023, and before that served in various roles of increasing responsibility at Milliken & Company culminating in the role of Executive Vice President and Division President, Chemicals. Dr. Moody has over thirty years’ experience managing chemical and polymer related businesses in various leadership roles and holds a Bachelor of Science in Chemistry from Wofford College and a Ph.D. in Chemistry from the Georgia Institute of Technology. Richard N. Altice most recently retired from NatureWorks, a developer and manufacturer of biopolymers (polylactic acid), where he served as President and CEO for five years. Prior to NatureWorks, Mr. Altice was the Senior Vice President and President of PolyOne’s Designed Structures and Solutions, a polymer and plastics converting and food packaging business, formerly known as Spartech. Additionally, Mr. Altice was Vice President of Hexion’s Global Specialty Epoxy resin business and was formerly the President of Solutia’s Technical Specialties division, responsible for the global rubber chemicals and specialty fluids businesses. Mr. Altice has over thirty years of sales, marketing, operational and management experience in the specialty chemicals and biopolymer industries and holds a Bachelor of Science in Chemical Engineering from the Missouri University of Science and Technology. With these changes, Danimer’s Board will be comprised of eleven directors.
お知らせ • Nov 08Danimer Scientific, Inc. to Report Q3, 2023 Results on Nov 14, 2023Danimer Scientific, Inc. announced that they will report Q3, 2023 results After-Market on Nov 14, 2023
お知らせ • Oct 20Danimer Scientific, BIOLO and Bolthouse Farms Announce Commercialization of Home Compostable Packaging for Fresh Produce with Meijer StoresDanimer Scientific, Inc. announced the commercialization of home compostable retail packaging for vegetables and fruit, which Danimer developed in partnership with biodegradable packaging and food service product manufacturer BIOLO and carrot producer Bolthouse Farms. Danimer’s signature PHA, Nodax®, was used to create the bags for one-pound Earthbound Farm Organic Mini Peeled Carrots, now available in Meijer’s regional network of 240 grocery stores and supercenters in six states across the Midwest. Danimer’s Nodax® is a biobased polyester made with oils derived from the seeds of plants such as canola. Unlike traditional plastic, which can take centuries to degrade, Danimer’s PHA-based products can degrade in a matter of months under certain conditions. The Earthbound Farm Organic Mini Peeled Carrots bags are certified as home compostable by TUV, a globally recognized leader in independent product testing, inspection and certification. This certification means that the bags have passed rigorous testing that requires them to disintegrate at least 90% within 26 weeks and biodegrade within 52 weeks under home compost conditions.
お知らせ • Aug 01Danimer Scientific, Inc. to Report Q2, 2023 Results on Aug 08, 2023Danimer Scientific, Inc. announced that they will report Q2, 2023 results After-Market on Aug 08, 2023
お知らせ • May 04Danimer Scientific, Inc. to Report Q1, 2023 Results on May 10, 2023Danimer Scientific, Inc. announced that they will report Q1, 2023 results at 4:00 PM, US Eastern Standard Time on May 10, 2023
お知らせ • Nov 09Danimer Scientific, Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2022Danimer Scientific, Inc. reported impairment charges for the third quarter ended September 30, 2022. For the quarter, the company reported impairment of goodwill of $62,663,000.
お知らせ • Oct 26Danimer Scientific, Inc. to Report Q3, 2022 Results on Nov 08, 2022Danimer Scientific, Inc. announced that they will report Q3, 2022 results at 4:00 PM, US Eastern Standard Time on Nov 08, 2022
お知らせ • Sep 21Danimer Scientific Appoints Stephen Martin as Chief Legal Officer and Corporate SecretaryDanimer Scientific, Inc. announced it has appointed Stephen Martin as Chief Legal Officer and Corporate Secretary. In this role, Martin will manage a wide range of legal matters across the company as Danimer continues to expand its manufacturing capacity to meet demand in the fast-growing bioplastics market.Martin joins Danimer from Kaman Distribution Group, a leading national distributor of highly engineered products and services, where he had served as General Counsel and Corporate Secretary from 2020 until that company’s successful sale earlier this year. Before that, he was General Counsel and Corporate Secretary for Accuride Corporation, a vehicle components manufacturer, starting in 2008. Martin served as an officer in the Air Force from 1992 to 1998, managing the procurement of avionics systems for the Atlas Launch Vehicle system and serving on a satellite command and control squadron responsible for operating a constellation of satellites. He is a distinguished graduate of Squadron Officer School. Martin received his Juris Doctor from Duke University School of Law in 2001, graduating cum laude. He received his master’s from the University of Southern California and his bachelor’s degree from the University of Miami, both in electrical engineering.
Recent Insider Transactions • Aug 24Director recently sold €869k worth of stockOn the 19th of August, Stuart Pratt sold around 175k shares on-market at roughly €4.96 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
お知らせ • Aug 17Danimer Scientific, Inc. Elects Board MembersDanimer Scientific, Inc. held its Annual Meeting of Stockholders on August 11, 2022, elected Cynthia Cohen and Allison M. Leopold Tilley to its Board of Directors.
